Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.
Authors: Gettinger SN; Yale Cancer Center, New Haven, Connecticut., Redman MW; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla., Hirsch FR; Mount Sinai Health System, New York, New York., Mack PC; University of California Davis Comprehensive Cancer Center, Sacramento., Schwartz LH; Columbia University Medical College, New York, New York., Bradley JD; Washington University School of Medicine, St Louis, Missouri., Stinchcombe TE; Duke University School of Medicine, Durham, North Carolina., Leighl NB; Princess Margaret Hospital, Toronto, Ontario, Canada., Ramalingam SS; Department of Hematology and Oncology, Emory University, Atlanta, Georgia., Tavernier SS; Idaho State University School of Nursing, Pocatello., Yu H; Mount Sinai Health System, New York, New York., Unger JM; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Minichiello K; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Highleyman L; SWOG Statistical Center, Seattle, Washington., Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston., Kelly K; University of California Davis Comprehensive Cancer Center, Sacramento., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento., Herbst RS; Yale Cancer Center, New Haven, Connecticut.
Source: JAMA oncology [JAMA Oncol] 2021 Sep 01; Vol. 7 (9), pp. 1368-1377.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2374-2445
DOI:10.1001/jamaoncol.2021.2209